Chief Strategy Officer of Flexion Therapeutics Inc (NASDAQ:FLXN), Willwerth Christina, sells 6,602 shares worth $73,480

According to Flexion Therapeutics Inc's most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Jan 07 05:55 PM, company Chief Strategy Officer, Willwerth Christina disclosed selling 6,602 shares at a cost of $11.13. At the time of this transaction (Jan 05), this trade was worth $73,480 in total. As of Jan 05, Willwerth Christina now owns 115,186 shares in total worth about $1,440,976.8599999999.

For the last few recent trades made by Flexion Therapeutics Inc (NASDAQ:FLXN) Chief Strategy Officer, Willwerth Christina, we have the following information:

    Posted by on Thursday January 07 2021, 6:17 PM EDT. All trademarks acknowledged. Filed under Business, Stocks. Comments and Trackbacks closed. Follow responses: RSS 2.0

    Comments are closed

    Featured Press Releases

    Log in